China Biologic Products Holdings, Inc. (CBPO): Price and Financial Metrics
CBPO Price/Volume Stats
| Current price | $119.99 | 52-week high | $120.05 |
| Prev. close | $118.01 | 52-week low | $99.74 |
| Day low | $117.27 | Volume | 390,900 |
| Day high | $120.05 | Avg. volume | 148,695 |
| 50-day MA | $118.30 | Dividend yield | N/A |
| 200-day MA | $114.25 | Market Cap | 4.72B |
CBPO Stock Price Chart Interactive Chart >
China Biologic Products Holdings, Inc. (CBPO) Company Bio
China Biologic Products engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in China. The company is based in Beijing, the China.
Latest CBPO News From Around the Web
Below are the latest news stories about China Biologic Products Holdings Inc that investors may wish to consider to help them evaluate CBPO as an investment opportunity.
China Biologic Announces Completion of Going Private TransactionChina Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced the completion of its merger (the "Merger") with CBPO Group Limited ("Merger Sub"), a wholly owned subsidiary of CBPO Holdings Limited ("Parent"), pursuant to the previously announced agreement and plan of merger, dated as of November 19, 2020 (the "Merger Agreement") among the Company, Parent and Merger Sub. As a result of the Merger, the Company became a wholly owned subsidiary of Parent and will cease to be a publicly traded company. |
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the fourth quarter and fiscal year of 2020. |
10 Best Hong Kong Stocks To Buy For 2021In this article, we discussed Chinese billionaire Zhang Lei’s investment philosophy and his 10 best Hong Kong stocks to buy for 2021. Click to skip ahead and see 5 Best Hong Kong Stocks To Buy for 2021. Hillhouse Capital Group founder and Chinese billionaire Zhang Lei has generated strong returns over the years amid his […] |
China Biologic Announces Shareholders' Approval of Merger AgreementChina Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that, at an extraordinary general meeting (the "EGM") held today, the Company's shareholders voted in favor of the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of November 19, 2020 (the "Merger Agreement"), among the Company, CBPO Holdings Limited ("Parent") and CBPO Group Limited ("Merger Sub"), pursuant to which, Merger Sub will be merged with and into the Company with the Company continuing as the surviving company and becoming a wholly owned subsidiary of Parent (the "Merger"), the plan of merger (the "Plan of Merger") required to be filed with the Reg... |
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data ReadoutHere's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 17) Advaxis, Inc. (NASDAQ: ADXS ) Angion Biomedica Corp (NASDAQ: ANGN ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Avanos Medical Inc (NYSE: AVNS ) Bausch Health Companies Inc (NYSE: BHC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bioatla Inc (NASDAQ: BCAB ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Chimerix Inc (NASDAQ: CMRX ) China Biologic Products Holdings Inc (NASDAQ: CBPO ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Endo International PLC (NASDAQ: ENDP ) Integra Lifesciences Holdings Corp (NASDA... |
CBPO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 8.15% |
| 5-year | 47.17% |
| YTD | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 1.49% |
| 2019 | 53.31% |
| 2018 | -3.63% |
Continue Researching CBPO
Want to see what other sources are saying about China Biologic Products Holdings Inc's financials and stock price? Try the links below:China Biologic Products Holdings Inc (CBPO) Stock Price | Nasdaq
China Biologic Products Holdings Inc (CBPO) Stock Quote, History and News - Yahoo Finance
China Biologic Products Holdings Inc (CBPO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...